SLC29A3 and hypolipoproteinemia: Consistently, Slc29a3−/− mouse plasma displayed severe dyslipidemic features, including hypocholesterolemia, hypotriglyceridemia, and hypolipoproteinemia (Supplementary Fig. 10a).